Engineered immune cells take on deadly brain tumors
Disease control
Terminated
This early-stage trial tests a new treatment for people with a severe type of brain cancer (grade 4 glioma) that has come back or not responded to standard therapies. The treatment uses the patient's own immune cells, modified in a lab to target a protein called IL-13Rα2 found on…
Phase: PHASE1 • Sponsor: Yang Zhang • Aim: Disease control
Last updated May 08, 2026 12:03 UTC